| Use of CAR-transduced natural killer cells in CD19-positive lymphoid tumors E Liu, D Marin, P Banerjee, HA Macapinlac, P Thompson, R Basar, ... New England Journal of Medicine 382 (6), 545-553, 2020 | 1851 | 2020 |
| Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia A Ferrajoli, BN Lee, EJ Schlette, SM O'Brien, H Gao, S Wen, WG Wierda, ... Blood, The Journal of the American Society of Hematology 111 (11), 5291-5297, 2008 | 530 | 2008 |
| Epithelial–mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer A Giordano, H Gao, S Anfossi, E Cohen, M Mego, BN Lee, S Tin, ... Molecular cancer therapeutics 11 (11), 2526-2534, 2012 | 249 | 2012 |
| Expression of epithelial–mesenchymal transition‐inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy M Mego, SA Mani, BN Lee, C Li, KW Evans, EN Cohen, H Gao, ... International journal of cancer 130 (4), 808-816, 2012 | 188 | 2012 |
| Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination M Giuliano, A Giordano, S Jackson, U De Giorgi, M Mego, EN Cohen, ... Breast cancer research 16, 1-9, 2014 | 157 | 2014 |
| Detection of minimal residual disease in blood and bone marrow in early stage breast cancer S Krishnamurthy, M Cristofanilli, B Singh, J Reuben, H Gao, EN Cohen, ... Cancer 116 (14), 3330-3337, 2010 | 149 | 2010 |
| Inflammation mediated metastasis: immune induced epithelial-to-mesenchymal transition in inflammatory breast cancer cells EN Cohen, H Gao, S Anfossi, M Mego, NG Reddy, B Debeb, A Giordano, ... PloS one 10 (7), e0132710, 2015 | 131 | 2015 |
| Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44+ CD24lo cancer stem … JM Reuben, BN Lee, H Gao, EN Cohen, M Mego, A Giordano, X Wang, ... European journal of cancer 47 (10), 1527-1536, 2011 | 123 | 2011 |
| Treatment with lenalidomide modulates T‐cell immunophenotype and cytokine production in patients with chronic lymphocytic leukemia BN Lee, H Gao, EN Cohen, X Badoux, WG Wierda, Z Estrov, SH Faderl, ... Cancer 117 (17), 3999-4008, 2011 | 103 | 2011 |
| Circulating tumor cells (CTC) are associated with defects in adaptive immunity in patients with inflammatory breast cancer M Mego, H Gao, EN Cohen, S Anfossi, A Giordano, T Sanda, TM Fouad, ... Journal of Cancer 7 (9), 1095, 2016 | 97 | 2016 |
| High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast … S Anfossi, A Giordano, H Gao, EN Cohen, S Tin, Q Wu, RJ Garza, ... PloS one 9 (1), e83113, 2014 | 96 | 2014 |
| Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells BG Debeb, X Zhang, S Krishnamurthy, H Gao, E Cohen, L Li, ... Molecular cancer 9, 1-12, 2010 | 91 | 2010 |
| Inflammatory markers and development of symptom burden in patients with multiple myeloma during autologous stem cell transplantation XS Wang, Q Shi, ND Shah, CJ Heijnen, EN Cohen, JM Reuben, ... Clinical Cancer Research 20 (5), 1366-1374, 2014 | 85 | 2014 |
| Prognostic value of EMT-circulating tumor cells in metastatic breast cancer patients undergoing high-dose chemotherapy with autologous hematopoietic stem cell transplantation M Mego, H Gao, BN Lee, EN Cohen, S Tin, A Giordano, Q Wu, P Liu, ... Journal of Cancer 3, 369, 2012 | 85 | 2012 |
| Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells BG Debeb, EN Cohen, K Boley, EM Freiter, L Li, FM Robertson, ... Breast cancer research and treatment 134, 495-510, 2012 | 83 | 2012 |
| The role of thalidomide and placebo for the treatment of cancer-related anorexia-cachexia symptoms: results of a double-blind placebo-controlled randomized study S Yennurajalingam, JS Willey, JL Palmer, J Allo, ED Fabbro, EN Cohen, ... Journal of palliative medicine 15 (10), 1059-1064, 2012 | 82 | 2012 |
| Synthetic tumor‐specific breakpoint peptide vaccine in patients with chronic myeloid leukemia and minimal residual disease: a phase 2 trial N Jain, JM Reuben, H Kantarjian, C Li, H Gao, BN Lee, EN Cohen, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2009 | 75 | 2009 |
| Modification of a hydrophobic layer by a point mutation in syntaxin 1A regulates the rate of synaptic vesicle fusion RD Lagow, H Bao, EN Cohen, RW Daniels, A Zuzek, WH Williams, ... PLoS biology 5 (4), e72, 2007 | 60 | 2007 |
| Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer M Mego, H Gao, EN Cohen, S Anfossi, A Giordano, S Tin, TM Fouad, ... Oncotarget 8 (22), 35656, 2016 | 57 | 2016 |
| Immune responses in adult female volunteers during the bed-rest model of spaceflight: antibodies and cytokines WT Shearer, HD Ochs, BN Lee, EN Cohen, JM Reuben, I Cheng, ... Journal of Allergy and Clinical Immunology 123 (4), 900-905, 2009 | 55 | 2009 |
Naoto T UenoUniversity of Hawaiʻi Cancer CenterVerified email at cc.hawaii.edu
